Hsu WC, Yen AM, Liou HH, et al. Prevalence and risk factors of somatic and autonomic neuropathy in predia-betic and diabetic patients[J]. Neuroepidemiology, 2009, 33(4): 344-349.
[2]
Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community[J]. Diabetes Care, 2008, 31(9): 1837-1841.
[3]
Pradeepa R, Rema M, Vignesh J, et al. Prevalence and risk factors for diabetic neuropathy in an urban south Indian pop-ulation: the Chennai Urban Rural Epidemiology Study (CURES-55)[J]. Diabet Med, 2008, 25(4): 407-412.
[4]
Tres GS, Lisboa HR, Syllos R, et al. Prevalence and characteristics of diabetic po1yneuropathy in Passo Fundo, South of Brazil[J]. Arq Bras Endocrinol Metabol, 2007, 51(6): 987-992.
Feng Y, Schlosser FJ, Sumpio BE. The Semmes Wein-stein monofilament examination as a screening tool for diabetic peripheral neuropathy[J]. J Vasc Surg, 2009, 50(3): 675-682.
[7]
Dros J, Wewerinke A, Bindels P J, et al. Accuracy of monofilament testing to diagnose peripheral neuropathy: asystematic review[J]. Ann Faro Med, 2009, 7(6): 555-558.
[8]
Wooten K. Clinical features and electrodiagnosis of diabet-ic peripheral neuropathy in the dysvascular patient[J]. Phys Med Rehabil Clin N Am, 2009, 20(4): 657-676.
[9]
Hyllienmark L, Jonsson B, Ekberg K, et al. Abnormal cold perception in the lower limbs: a sensitive indicator for detection of polyneuropathy in patients with type 1 diabetes mellitus[J]. Diabetes Res Clin Pract, 2009, 85(3): 298-303.
[10]
Sommer C. Skin biopsy as a diagnostic tool[J]. Curr Opin Neurol, 2008, 21(5): 563-568.
